Page last updated: 2024-10-26

valproic acid and Pseudohypoparathyroidism

valproic acid has been researched along with Pseudohypoparathyroidism in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Pseudohypoparathyroidism: A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robinson, PB1
Harris, M1
Harvey, W1
Papadogeorgakis, N1

Other Studies

1 other study available for valproic acid and Pseudohypoparathyroidism

ArticleYear
Reduced bone growth in rats treated with anticonvulsant drugs: a type II pseudohypoparathyroidism?
    Metabolic bone disease & related research, 1982, Volume: 4, Issue:4

    Topics: Animals; Anticonvulsants; Bone and Bones; Bone Development; Calcium; Female; Male; Parathyroid Gland

1982